3.26.1 html 290 404 1 false 85 0 false 7 false false R1.htm 995200090 - Document - Document and Entity Information Sheet http://www.aeonbiopharma.com/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 995200100 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://www.aeonbiopharma.com/role/StatementConsolidatedBalanceSheets CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 995200105 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://www.aeonbiopharma.com/role/StatementConsolidatedBalanceSheetsParenthetical CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 995200200 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE (LOSS) INCOME Sheet http://www.aeonbiopharma.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLossIncome CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE (LOSS) INCOME Statements 4 false false R5.htm 995200300 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT Sheet http://www.aeonbiopharma.com/role/StatementConsolidatedStatementsOfStockholdersDeficit CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT Statements 5 false false R6.htm 995200400 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.aeonbiopharma.com/role/StatementConsolidatedStatementsOfCashFlows CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 6 false false R7.htm 995210101 - Disclosure - Organization Sheet http://www.aeonbiopharma.com/role/DisclosureOrganization Organization Notes 7 false false R8.htm 995210201 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.aeonbiopharma.com/role/DisclosureSummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 8 false false R9.htm 995210301 - Disclosure - Public Offering Sheet http://www.aeonbiopharma.com/role/DisclosurePublicOffering Public Offering Notes 9 false false R10.htm 995210401 - Disclosure - Private Placement Financing Sheet http://www.aeonbiopharma.com/role/DisclosurePrivatePlacementFinancing Private Placement Financing Notes 10 false false R11.htm 995210501 - Disclosure - Daewoong Convertible Notes Notes http://www.aeonbiopharma.com/role/DisclosureDaewoongConvertibleNotes Daewoong Convertible Notes Notes 11 false false R12.htm 995210601 - Disclosure - Fair Value Measurements Sheet http://www.aeonbiopharma.com/role/DisclosureFairValueMeasurements Fair Value Measurements Notes 12 false false R13.htm 995210701 - Disclosure - Commitments and Contingencies Sheet http://www.aeonbiopharma.com/role/DisclosureCommitmentsAndContingencies Commitments and Contingencies Notes 13 false false R14.htm 995210801 - Disclosure - Income Taxes Sheet http://www.aeonbiopharma.com/role/DisclosureIncomeTaxes Income Taxes Notes 14 false false R15.htm 995210901 - Disclosure - Common Stock Sheet http://www.aeonbiopharma.com/role/DisclosureCommonStock Common Stock Notes 15 false false R16.htm 995211001 - Disclosure - Share-based Compensation Stock Incentive Plans Sheet http://www.aeonbiopharma.com/role/DisclosureShareBasedCompensationStockIncentivePlans Share-based Compensation Stock Incentive Plans Notes 16 false false R17.htm 995211101 - Disclosure - Subsequent Events Sheet http://www.aeonbiopharma.com/role/DisclosureSubsequentEvents Subsequent Events Notes 17 false false R18.htm 995410 - Disclosure - Pay vs Performance Disclosure Sheet http://xbrl.sec.gov/ecd/role/PvpDisclosure Pay vs Performance Disclosure Notes 18 false false R19.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 19 false false R20.htm 995447 - Disclosure - Insider Trading Policies and Procedures Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc Insider Trading Policies and Procedures Notes 20 false false R21.htm 995550 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure Sheet http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure Cybersecurity Risk Management and Strategy Disclosure Notes 21 false false R22.htm 99920202 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.aeonbiopharma.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://www.aeonbiopharma.com/role/DisclosureSummaryOfSignificantAccountingPolicies 22 false false R23.htm 99930203 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://www.aeonbiopharma.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://www.aeonbiopharma.com/role/DisclosureSummaryOfSignificantAccountingPolicies 23 false false R24.htm 99930603 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.aeonbiopharma.com/role/DisclosureFairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.aeonbiopharma.com/role/DisclosureFairValueMeasurements 24 false false R25.htm 99930703 - Disclosure - Commitments and Contingencies (Tables) Sheet http://www.aeonbiopharma.com/role/DisclosureCommitmentsAndContingenciesTables Commitments and Contingencies (Tables) Tables http://www.aeonbiopharma.com/role/DisclosureCommitmentsAndContingencies 25 false false R26.htm 99930803 - Disclosure - Income Taxes (Tables) Sheet http://www.aeonbiopharma.com/role/DisclosureIncomeTaxesTables Income Taxes (Tables) Tables http://www.aeonbiopharma.com/role/DisclosureIncomeTaxes 26 false false R27.htm 99930903 - Disclosure - Common Stock (Tables) Sheet http://www.aeonbiopharma.com/role/DisclosureCommonStockTables Common Stock (Tables) Tables http://www.aeonbiopharma.com/role/DisclosureCommonStock 27 false false R28.htm 99931003 - Disclosure - Share-based Compensation Stock Incentive Plans (Tables) Sheet http://www.aeonbiopharma.com/role/DisclosureShareBasedCompensationStockIncentivePlansTables Share-based Compensation Stock Incentive Plans (Tables) Tables http://www.aeonbiopharma.com/role/DisclosureShareBasedCompensationStockIncentivePlans 28 false false R29.htm 99940101 - Disclosure - Organization (Details) Sheet http://www.aeonbiopharma.com/role/DisclosureOrganizationDetails Organization (Details) Details http://www.aeonbiopharma.com/role/DisclosureOrganization 29 false false R30.htm 99940201 - Disclosure - Summary of Significant Accounting Policies - Segment Reporting (Details) Sheet http://www.aeonbiopharma.com/role/DisclosureSummaryOfSignificantAccountingPoliciesSegmentReportingDetails Summary of Significant Accounting Policies - Segment Reporting (Details) Details 30 false false R31.htm 99940202 - Disclosure - Summary of Significant Accounting Policies - Property and Equipment (Details) Sheet http://www.aeonbiopharma.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails Summary of Significant Accounting Policies - Property and Equipment (Details) Details 31 false false R32.htm 99940203 - Disclosure - Summary of Significant Accounting Policies - Other Accrued Expenses (Details) Sheet http://www.aeonbiopharma.com/role/DisclosureSummaryOfSignificantAccountingPoliciesOtherAccruedExpensesDetails Summary of Significant Accounting Policies - Other Accrued Expenses (Details) Details 32 false false R33.htm 99940204 - Disclosure - Summary of Significant Accounting Policies - Derivative Liability (Details) Sheet http://www.aeonbiopharma.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDerivativeLiabilityDetails Summary of Significant Accounting Policies - Derivative Liability (Details) Details 33 false false R34.htm 99940205 - Disclosure - Summary of Significant Accounting Policies - Net Loss Per Share Attributable to Common Stockholders (Details) Sheet http://www.aeonbiopharma.com/role/DisclosureSummaryOfSignificantAccountingPoliciesNetLossPerShareAttributableToCommonStockholdersDetails Summary of Significant Accounting Policies - Net Loss Per Share Attributable to Common Stockholders (Details) Details 34 false false R35.htm 99940206 - Disclosure - Summary of Significant Accounting Policies - Potentially Dilutive Securities Outstanding (Details) Sheet http://www.aeonbiopharma.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPotentiallyDilutiveSecuritiesOutstandingDetails Summary of Significant Accounting Policies - Potentially Dilutive Securities Outstanding (Details) Details 35 false false R36.htm 99940301 - Disclosure - Public Offering (Details) Sheet http://www.aeonbiopharma.com/role/DisclosurePublicOfferingDetails Public Offering (Details) Details http://www.aeonbiopharma.com/role/DisclosurePublicOffering 36 false false R37.htm 99940401 - Disclosure - Private Placement Financing (Details) Sheet http://www.aeonbiopharma.com/role/DisclosurePrivatePlacementFinancingDetails Private Placement Financing (Details) Details http://www.aeonbiopharma.com/role/DisclosurePrivatePlacementFinancing 37 false false R38.htm 99940501 - Disclosure - Daewoong Convertible Notes (Details) Notes http://www.aeonbiopharma.com/role/DisclosureDaewoongConvertibleNotesDetails Daewoong Convertible Notes (Details) Details http://www.aeonbiopharma.com/role/DisclosureDaewoongConvertibleNotes 38 false false R39.htm 99940601 - Disclosure - Fair Value Measurements - Convertible Notes at Fair Value (Details) Notes http://www.aeonbiopharma.com/role/DisclosureFairValueMeasurementsConvertibleNotesAtFairValueDetails Fair Value Measurements - Convertible Notes at Fair Value (Details) Details 39 false false R40.htm 99940602 - Disclosure - Fair Value Measurements - Contingent Consideration and Contingent Founder Shares (Details) Sheet http://www.aeonbiopharma.com/role/DisclosureFairValueMeasurementsContingentConsiderationAndContingentFounderSharesDetails Fair Value Measurements - Contingent Consideration and Contingent Founder Shares (Details) Details 40 false false R41.htm 99940603 - Disclosure - Fair Value Measurements - Public and Private Placement Warrants related to the Closing (Details) Sheet http://www.aeonbiopharma.com/role/DisclosureFairValueMeasurementsPublicAndPrivatePlacementWarrantsRelatedToClosingDetails Fair Value Measurements - Public and Private Placement Warrants related to the Closing (Details) Details 41 false false R42.htm 99940604 - Disclosure - Fair Value Measurements - Significant inputs as of the valuation dates (Details) Sheet http://www.aeonbiopharma.com/role/DisclosureFairValueMeasurementsSignificantInputsAsOfValuationDatesDetails Fair Value Measurements - Significant inputs as of the valuation dates (Details) Details 42 false false R43.htm 99940605 - Disclosure - Fair Value Measurements - Summary of the Company's issued and outstanding public warrants (Details) Sheet http://www.aeonbiopharma.com/role/DisclosureFairValueMeasurementsSummaryOfCompanySIssuedAndOutstandingPublicWarrantsDetails Fair Value Measurements - Summary of the Company's issued and outstanding public warrants (Details) Details 43 false false R44.htm 99940606 - Disclosure - Fair Value Measurements - Company's recurring measurements for assets and liabilities at fair value (Details) Sheet http://www.aeonbiopharma.com/role/DisclosureFairValueMeasurementsCompanySRecurringMeasurementsForAssetsAndLiabilitiesAtFairValueDetails Fair Value Measurements - Company's recurring measurements for assets and liabilities at fair value (Details) Details 44 false false R45.htm 99940701 - Disclosure - Commitments and Contingencies - Supplemental balance sheet information related to the operating lease (Details) Sheet http://www.aeonbiopharma.com/role/DisclosureCommitmentsAndContingenciesSupplementalBalanceSheetInformationRelatedToOperatingLeaseDetails Commitments and Contingencies - Supplemental balance sheet information related to the operating lease (Details) Details 45 false false R46.htm 99940702 - Disclosure - Commitments and Contingencies - Supplemental disclosures of operating cost and cash flow information related to operating leases (Details) Sheet http://www.aeonbiopharma.com/role/DisclosureCommitmentsAndContingenciesSupplementalDisclosuresOfOperatingCostAndCashFlowInformationRelatedToOperatingLeasesDetails Commitments and Contingencies - Supplemental disclosures of operating cost and cash flow information related to operating leases (Details) Details 46 false false R47.htm 99940703 - Disclosure - Commitments and Contingencies - Daewoong License and Supply Agreement (Details) Sheet http://www.aeonbiopharma.com/role/DisclosureCommitmentsAndContingenciesDaewoongLicenseAndSupplyAgreementDetails Commitments and Contingencies - Daewoong License and Supply Agreement (Details) Details 47 false false R48.htm 99940704 - Disclosure - Commitments and Contingencies - Legal Proceedings (Details) Sheet http://www.aeonbiopharma.com/role/DisclosureCommitmentsAndContingenciesLegalProceedingsDetails Commitments and Contingencies - Legal Proceedings (Details) Details 48 false false R49.htm 99940801 - Disclosure - Income Taxes (Details) Sheet http://www.aeonbiopharma.com/role/DisclosureIncomeTaxesDetails Income Taxes (Details) Details http://www.aeonbiopharma.com/role/DisclosureIncomeTaxesTables 49 false false R50.htm 99940802 - Disclosure - Income Taxes - components of deferred tax assets and liabilities (Details) Sheet http://www.aeonbiopharma.com/role/DisclosureIncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesDetails Income Taxes - components of deferred tax assets and liabilities (Details) Details 50 false false R51.htm 99940803 - Disclosure - Income Taxes - Income Tax Rate Reconciliation (Details) Sheet http://www.aeonbiopharma.com/role/DisclosureIncomeTaxesIncomeTaxRateReconciliationDetails Income Taxes - Income Tax Rate Reconciliation (Details) Details 51 false false R52.htm 99940804 - Disclosure - Income Taxes - Reconciliation of unrecognized tax benefits (Details) Sheet http://www.aeonbiopharma.com/role/DisclosureIncomeTaxesReconciliationOfUnrecognizedTaxBenefitsDetails Income Taxes - Reconciliation of unrecognized tax benefits (Details) Details 52 false false R53.htm 99940805 - Disclosure - Income Taxes - Narratives (Details) Sheet http://www.aeonbiopharma.com/role/DisclosureIncomeTaxesNarrativesDetails Income Taxes - Narratives (Details) Details 53 false false R54.htm 99940901 - Disclosure - Common Stock (Details) Sheet http://www.aeonbiopharma.com/role/DisclosureCommonStockDetails Common Stock (Details) Details http://www.aeonbiopharma.com/role/DisclosureCommonStockTables 54 false false R55.htm 99940902 - Disclosure - Common Stock - Common stock reserved for future issuance (Details) Sheet http://www.aeonbiopharma.com/role/DisclosureCommonStockCommonStockReservedForFutureIssuanceDetails Common Stock - Common stock reserved for future issuance (Details) Details 55 false false R56.htm 99941001 - Disclosure - Share-based Compensation Stock Incentive Plans - Stock Incentive Plans (Details) Sheet http://www.aeonbiopharma.com/role/DisclosureShareBasedCompensationStockIncentivePlansStockIncentivePlansDetails Share-based Compensation Stock Incentive Plans - Stock Incentive Plans (Details) Details 56 false false R57.htm 99941002 - Disclosure - Share-based Compensation Stock Incentive Plans - Share-based Award Activity (Details) Sheet http://www.aeonbiopharma.com/role/DisclosureShareBasedCompensationStockIncentivePlansShareBasedAwardActivityDetails Share-based Compensation Stock Incentive Plans - Share-based Award Activity (Details) Details 57 false false R58.htm 99941003 - Disclosure - Share-based Compensation Stock Incentive Plans - Share-based Compensation Expense and Valuation Information (Details) Sheet http://www.aeonbiopharma.com/role/DisclosureShareBasedCompensationStockIncentivePlansShareBasedCompensationExpenseAndValuationInformationDetails Share-based Compensation Stock Incentive Plans - Share-based Compensation Expense and Valuation Information (Details) Details 58 false false R59.htm 99941101 - Disclosure - Subsequent Events - (Details) Sheet http://www.aeonbiopharma.com/role/DisclosureSubsequentEventsDetails Subsequent Events - (Details) Details http://www.aeonbiopharma.com/role/DisclosureSubsequentEvents 59 false false All Reports Book All Reports aeon-20251231.xsd aeon-20251231_cal.xml aeon-20251231_def.xml aeon-20251231_lab.xml aeon-20251231_pre.xml aeon-20251231x10k.htm http://fasb.org/us-gaap/2024 http://xbrl.sec.gov/cyd/2024 http://xbrl.sec.gov/dei/2024 http://xbrl.sec.gov/ecd/2024 true true